# The National Health Service (Charges, Remission of Charges and Pharmaceutical Services etc.) (Amendment and Transitional Provisions) Regulations 2025, Note: Explanatory note


(This note is not part of the Regulations)
These Regulations make amendments to the National Health Service (Travel Expenses and Remission of Charges) Regulations 2003 (the TERCS Regulations), the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (the PLPS Regulations) and the National Health Service (Charges for Drugs and Appliances) Regulations 2015 (the Charges Regulations).
As a consequence of tax credits ending on 5th April 2025, regulations 3, 4 and 5 make amendments to the TERCS Regulations to remove the NHS charge and NHS travel expenses exemption for those in receipt of tax credits where the individual (including their partner and dependent children) is in receipt of child tax credit, working tax credit and child tax credit paid together or working tax credit including a disability or severe disability element.
Currently Distance Selling Premises (DSPs) can enter into the NHS pharmaceutical services market on the basis of an exemption from the normal market entry test. They are not allowed to deliver essential services (including dispensing) on the pharmacy premises but they can deliver some clinical services face-to-face both there and elsewhere.
Regulations 7 and 8 amend the PLPS Regulations to require DSPs to deliver all NHS pharmaceutical services remotely and not face to face on the pharmacy premises and remove the exemption from the normal market entry test for new DSPs. DSP contractors already on the pharmaceutical list will continue to be able to apply to relocate or change ownership of their premises and in the situation where a DSP application for new inclusion on the pharmaceutical list is made before 23rd June 2025 such applications will be determined in accordance with the market entry test that was in effect before 23rd June 2025.
Regulation 9 amends regulation 64 of the PLPS Regulations to provide that DSP contractors will not be able to deliver directed services on pharmacy premises from 1st October 2025, but they will be able to continue delivering influenza and COVID-19 vaccinations on the premises until 31st March 2026.
Regulation 10 amends regulation 91A of the PLPS Regulations to enable pharmacies to access centrally procured influenza vaccine stock for children. Regulation 11 amends Schedule 4 of the PLPS Regulations to add a new basis, related to the level of use of a pharmacy, on which pharmacies will be able to apply for changes to their core opening hours, where the total number of hours for which they are open will stay the same.
Regulation 12 amends regulation 17 of the Charges Regulations to enable the automatic cancellation and refund of a pre-payment certificate to persons who become entitled to a maternity or medical exemption certificate.
A full impact assessment has not been produced for this instrument as no, or no significant, impact on the public sector is foreseen, and only a limited impact on the private sector, below the threshold for producing a full impact assessment.

---
Source: https://www.legislation.gov.uk/uksi/2025/636/note (the official version)
Page: https://openlegislation.uk/national-health-service-charges-remission-of-charges-and-pharmaceutical-services-etc-amendment-and-transitional-provisions-regulations-2025/note
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

